Document is current
Any future updates will be listed below
-
Authors
Sullivan, Patrick S. https://orcid.org/0000-0002-7728-0587
Copeland, Cillian https://orcid.org/0009-0008-3923-5794
Jarrett, James https://orcid.org/0000-0002-3570-8581
Mordi, Uche https://orcid.org/0009-0001-3663-9055
Kotsopoulos, Nikos https://orcid.org/0000-0002-8248-7697
Martins, Rui https://orcid.org/0000-0003-4200-3106
Tookes, Hansel E. https://orcid.org/0000-0002-2369-360X
-
Funding
Funding for this research was provided by:
Gilead Sciences
- License Information
-
More Information
Article History
Received: 14 July 2025
Accepted: 22 August 2025
First Online: 12 September 2025
Declarations
:
: This work was funded by Gilead. Authors Cillian Copeland, Rui Martins and Nikos Kotsopoulos are employees of Global Market Access Solutions, who were paid consultants to Gilead. Authors James Jarrett and Uche Mordi are employees of Gilead. Author Patrick S. Sullivan has received research grants and speaker fees from Gilead Sciences; he has also received research grants from Merck and ViiV Healthcare. Author Hansel E. Tookes has received grants from Gilead Sciences and ViiV Healthcare.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
